HEPHAISTOS Pharma is a startup based in France, 1 tracked investor.
Based in France, HEPHAISTOS Pharma is a startup founded in 2018. Brouky records 1 investor associated with the company.
HEPHAISTOS Pharma develops ONCO-Boost, a natural TLR4 agonist designed to stimulate patients' innate and adaptive immune systems to improve anti-tumor responses against immunologically cold tumors.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.